Batsheva Kerem

Title: Batsheva Kerem: Innovator in CFTR Gene Modulation

Introduction

Batsheva Kerem is a notable inventor based in Mevaseret Zion, Israel. She has made significant contributions to the field of genetic research, particularly in the modulation of the CFTR gene, which is crucial for various therapeutic applications.

Latest Patents

Batsheva Kerem holds 2 patents related to the restoration of CFTR function through splicing modulation. Her latest patents include oligonucleotides capable of binding to and modulating the splicing of the pre-mRNA of the CFTR gene. These compositions are designed to suppress exon skipping, which can be used in combination with additional CFTR therapeutics. The patents provide innovative methods and compositions that have the potential to enhance treatment options for patients with CFTR-related disorders.

Career Highlights

Batsheva Kerem is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Her work at Yissum has allowed her to focus on groundbreaking research that bridges the gap between scientific discovery and practical application in medicine.

Collaborations

Throughout her career, Batsheva has collaborated with esteemed colleagues, including Loren Price and Sue Fletcher. These partnerships have fostered an environment of innovation and have contributed to the advancement of her research.

Conclusion

Batsheva Kerem's contributions to the field of genetic research, particularly in CFTR gene modulation, highlight her role as a leading inventor. Her patents and collaborative efforts continue to pave the way for advancements in therapeutic strategies.